Open an account

Orthofix Medical

OFIX · NASDAQ

$9.85+$0.26 (+2.71%)TodayMarket closed ·
Prev close $9.59

About OFIX

Orthofix Medical, Inc. engages in the provision of medical devices. The company is headquartered in Lewisville, Texas and currently employs 1,605 full-time employees. The company offers a comprehensive portfolio of spinal hardware, bone growth therapies, limb reconstruction solutions, biologics and enabling technologies, including the 7D FLASH Navigation System. Its Global Spine segment offers two primary product categories: bone growth therapies and spinal implants, biologics, and enabling technologies. The company provides implantable medical devices, biologics, enabling technologies, and other regenerative solutions which aim to restore the quality of life of patients suffering from diseases and traumas of the spine. The company offers a variety of treatment solutions that incorporate multiple treatment modalities, such as mechanical, biological, and electromagnetic modes. Its Global Limb Reconstruction segment offers products and solutions for the underserved limb reconstruction market that encompasses four pillars: deformity correction, limb lengthening, complex fracture management, and limb preservation.

Employees
1,605
Headquarters
Lewisville, Texas
Listed
Apr 24, 1992
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
ir.orthofix.com

OFIX key statistics

Market cap
401.22M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
432.71K
Volume
335.29K
Open price
$9.68
High today
$9.95
Low today
$9.68
52 Week high
$16.99
52 Week low
$8.50

Orthofix Medical (OFIX) at a glance

As of Oct 20, 2026, Orthofix Medical (OFIX) shares are priced at $9.85, giving the company a market cap of 401.22M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $9.68 and $9.95. The current price is 1.8% above the day's low and 1.0% below its high.

Volume so far is 335.29K shares, below the average of 432.71K shares a day.

Over the past year Orthofix Medical has ranged from $8.50 to $16.99, and now sits 16% of the way up that range.

Orthofix Medical met or beat analyst EPS estimates in 7 of the last 8 quarters. In Q2 FY26 it reported -$0.39 per share against an estimate of -$0.4182.

The average analyst price target is $13.26, 34.6% above the current price, from 4 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

75%of 4 analyst ratings say Buy
  • Buy75.0%
  • Hold25.0%
  • Sell0.0%
Price target · 6 analystsAvg $13.26
Low
$12.12
Now
$9.85
High
$14.70

OFIX earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 7 of the last 8 quarters, by 77.7% on average.

  1. Q3 FY24: reported $0.07 per share against an estimate of -$0.153
  2. Q4 FY24: reported $0.02 per share against an estimate of -$0.051
  3. Q1 FY25: reported -$0.08 per share against an estimate of -$0.4039
  4. Q2 FY25: reported -$0.45 per share against an estimate of -$0.4998
  5. Q3 FY25: reported -$0.57 per share against an estimate of -$0.4148
  6. Q4 FY25: reported -$0.06 per share against an estimate of -$0.3162
  7. Q1 FY26: reported -$0.13 per share against an estimate of -$0.6936
  8. Q2 FY26: reported -$0.39 per share against an estimate of -$0.4182

OFIX news

  • Press releasePRNewswire

    Did Orthofix Medical Inc. Insiders Breach their Fiduciary Duties to Shareholders?

  • Press releasePRNewswire

    SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duties by Certain Officers and Directors of Orthofix Medical Inc. (NASDAQ: OFIX)

  • 12 Health Care Stocks Moving In Wednesday's After-Market Session

  • 12 Health Care Stocks Moving In Wednesday's Pre-Market Session

  • Press releaseBusiness Wire

    Orthofix Reports Second Quarter 2026 Results Reflecting Continued Operational Progress

  • Press releasePRNewswire

    Did Orthofix Medical Inc. Insiders Breach their Fiduciary Duties to Shareholders?

  • Piero Cingari

    These 7 Small Caps Are on Fire as the Second Half Begins: Here’s Why

  • Press releasePRNewswire

    MedTech Pioneer Max Reinhardt Joins eXeX to Drive Canopus Platform Growth

Similar companies

Companies in the same industry as Orthofix Medical

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.